Investors & Media

Latest Presentations and Publications

Scientific Presentations
Scientific Publications

Latest Presentations

All Presentations

Sangamo Corporate Presentation

Nov 12, 2024

Sangamo Corporate Presentation 6.4 MB

Source ASH 2024

Efficacy and Safety of Giroctocogene Fitelparvovec in Adults With Moderately Severe to Severe Hemophilia A: Primary Analysis Results From the Phase 3 AFFINE Gene Therapy Trial

Dec 09, 2024

Efficacy and Safety of Giroctocogene Fitelparvovec in Adults With Moderately Severe to Severe Hemophilia A: Primary Analysis Results From the Phase 3 AFFINE Gene Therapy Trial 614 KB

Source Prion 2024 presentation

Single Intravenous Treatment with Zinc Finger Repressor Leads to Brainwide Reduction of Prion in Nonhuman Primates and Significantly Prolongs Survival in the RML Mouse Model

Nov 01, 2024

Single Intravenous Treatment with Zinc Finger Repressor Leads to Brainwide Reduction of Prion in Nonhuman Primates and Significantly Prolongs Survival in the RML Mouse Model 5.5 MB

Potent and selective repression of SCN9A by engineered zinc finger repressors for the treatment of neuropathic pain

Sep 11, 2024

Potent and selective repression of SCN9A by engineered zinc finger repressors f…

Source ASGCT 2024

Epigenetic Regulation of Human Prion Expression as a Potential One-Time Treatment for Prion Disease

May 07, 2024

Epigenetic Regulation of Human Prion Expression as a Potential One-Time Treatment for Prion Disease 17.1 MB

Source ASGCT 2024

Identification and characterization of STAC-BBB, an engineered AAV capsid that exhibits widespread transduction of the central nervous system in cynomolgus macaques

May 08, 2024

ASGCT 2024 6.1 MB

Source ASGCT 2024

Widespread CNS Tau Knockdown for the Potential Treatment of Alzheimer’s Disease and other Tauopathies

May 07, 2024

16. [Poster] SGMO_ASGCT 2024_Zeitler_1126_Tau_Resized.pdf 19 MB

Source ASGCT 2024

Directed evolution of Bxb1 for the development of Modular Integrases (MINTs)

May 09, 2024

Directed evolution of Bxb1 for the development of Modular Integrases (MINTs) 2.8 MB

Source ASGCT 2024

Site-directed integration of large DNA sequences into endogenous sites in the human genome using engineered Modular Integrases (MINTS)

May 07, 2024

06. [Poster] SGMO_ASGCT 2024_Fauser_1680_Integrase_Resized.pdf 3.4 MB

Corporate Call and Q4 Update – STAC-BBB deep-dive

Mar 13, 2024

Corporate Call and Q4 Update – STAC-BBB deep-dive 6.2 MB

Source WORLDSymposium™ 2024

Isaralgagenecivaparvovec(ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR)

Feb 05, 2024

Isaralgagenecivaparvovec(ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR) 1.2 MB

Source WORLDSymposium™ 2024

Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR)

Feb 05, 2024

Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR) 3.2 MB

Latest Publications

All Presentations

Potent and selective repression of SCN9A by engineered zinc finger repressors for the treatment of neuropathic pain

September 11, 2024

Potent and selective repression of SCN9A by engineered zinc finger repressors f…

Systematic Development of Reprogrammed Modular Integrases Enables Precise Genomic Integration of Large DNA Sequences

May 10, 2024

Systematic Development of Reprogrammed Modular Integrases Enables Precise Genom…